Oncology Pharma Inc (ONPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2003 | 06-2003 | 03-2003 | 12-2002 | 09-2002 | |
| Sales | 421 | 527 | 914 | 741 | 719 |
| Cost of Goods | 230 | 230 | 340 | 300 | 270 |
| Gross Profit | 180 | 290 | 600 | 430 | 440 |
| Operating Expenses | 840 | 880 | 1,140 | 1,270 | 1,230 |
| Operating Income | -419 | -353 | -226 | -529 | -511 |
| Other Income | -11 | -17 | 26 | -11 | 1 |
| Pre-tax Income | -430 | -370 | -200 | -540 | -510 |
| Net Income Continuous | -433 | -371 | -184 | -547 | -510 |
| Net Income | $-433 | $-371 | $-184 | $-547 | $-510 |
| EPS Basic Total Ops | -20,000,000.00 | -20,000,000.00 | -9,999,999.00 | -30,000,000.00 | -25,000,000.00 |
| EPS Basic Continuous Ops | -20,000,000.00 | -20,000,000.00 | -9,999,999.00 | -30,000,000.00 | -25,000,000.00 |
| EPS Diluted Total Ops | -20,000,000.00 | -20,000,000.00 | -9,999,999.00 | -30,000,000.00 | -25,000,000.00 |
| EPS Diluted Continuous Ops | -20,000,000.00 | -20,000,000.00 | -9,999,999.00 | -30,000,000.00 | -25,000,000.00 |
| EBITDA(a) | $-399 | $-333 | $-136 | $-429 | $-411 |